 id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Y</given-names></name><name><surname>Tsao</surname><given-names>BP</given-names></name></person-group><article-title>Genetic susceptibility to systemic lupus erythematosus in the genomic era</article-title><source>Nature reviews. Rheumatology</source><year>2010</year><volume>6</volume><fpage>683</fpage><lpage>692</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2010.176</pub-id><?supplied-pmid 21060334?><pub-id pub-id-type="pmid">21060334</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Psarras, A., Emery, P. &#x00026; Vital, E. M. Type I interferon-mediated autoimmune diseases: pathogenesis, diagnosis and targeted therapy. <italic>Rheumatology (Oxford)</italic>, 10.1093/rheumatology/kew431 (2017).</mixed-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conigliaro</surname><given-names>P</given-names></name><etal/></person-group><article-title>The type I IFN system in rheumatoid arthritis</article-title><source>Autoimmunity</source><year>2010</year><volume>43</volume><fpage>220</fpage><lpage>225</lpage><pub-id pub-id-type="doi">10.3109/08916930903510914</pub-id><?supplied-pmid 20166872?><pub-id pub-id-type="pmid">20166872</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Jong</surname><given-names>TD</given-names></name><etal/></person-group><article-title>The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes</article-title><source>Arthritis Res Ther</source><year>2016</year><volume>18</volume><fpage>165</fpage><pub-id pub-id-type="doi">10.1186/s13075-016-1065-3</pub-id><?supplied-pmid 27411379?><pub-id pub-id-type="pmid">27411379</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiche</surname><given-names>L</given-names></name><name><surname>Jourde-Chiche</surname><given-names>N</given-names></name><name><surname>Pascual</surname><given-names>V</given-names></name><name><surname>Chaussabel</surname><given-names>D</given-names></name></person-group><article-title>Current perspectives on systems immunology approaches to rheumatic diseases</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>1407</fpage><lpage>1417</lpage><pub-id pub-id-type="doi">10.1002/art.37909</pub-id><?supplied-pmid 23450649?><pub-id pub-id-type="pmid">23450649</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiche</surname><given-names>L</given-names></name><etal/></person-group><article-title>Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures</article-title><source>Arthritis Rheumatol</source><year>2014</year><volume>66</volume><fpage>1583</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1002/art.38628</pub-id><?supplied-pmid 24644022?><pub-id pub-id-type="pmid">24644022</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><name><surname>Gkrouzman</surname><given-names>E</given-names></name></person-group><article-title>Anti-interferon alpha treatment in SLE</article-title><source>Clin Immunol</source><year>2013</year><volume>148</volume><fpage>303</fpage><lpage>312</lpage><pub-id pub-id-type="doi">10.1016/j.clim.2013.02.013</pub-id><?supplied-pmid 23566912?><pub-id pub-id-type="pmid">23566912</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: results of a phase I, placebo-controlled, double-blind, dose-escalation study</article-title><source>Arthritis Rheum</source><year>2012</year><volume>64</volume><fpage>3666</fpage><lpage>3676</lpage><pub-id pub-id-type="doi">10.1002/art.34632</pub-id><?supplied-pmid 22833362?><pub-id pub-id-type="pmid">22833362</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>M</given-names></name><etal/></person-group><article-title>Sifalimumab, a human anti-interferon-alpha monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>1011</fpage><lpage>1021</lpage><pub-id pub-id-type="doi">10.1002/art.37824</pub-id><?supplied-pmid 23400715?><pub-id pub-id-type="pmid">23400715</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauwerys</surname><given-names>BR</given-names></name><name><surname>Ducreux</surname><given-names>J</given-names></name><name><surname>Houssiau</surname><given-names>FA</given-names></name></person-group><article-title>Type I interferon blockade in systemic lupus erythematosus: where do we stand?</article-title><source>Rheumatology (Oxford)</source><year>2014</year><volume>53</volume><fpage>1369</fpage><lpage>1376</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/ket403</pub-id><pub-id pub-id-type="pmid">24344319</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>WP</given-names></name><etal/></person-group><article-title>Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE</article-title><source>Lupus Sci Med</source><year>2015</year><volume>2</volume><fpage>e000080</fpage><pub-id pub-id-type="doi">10.1136/lupus-2014-000080</pub-id><?supplied-pmid 25861459?><pub-id pub-id-type="pmid">25861459</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>GI</given-names></name><etal/></person-group><article-title>Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study</article-title><source>Lancet Neurol</source><year>2013</year><volume>12</volume><fpage>1159</fpage><lpage>1169</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70258-8</pub-id><?supplied-pmid 24183309?><pub-id pub-id-type="pmid">24183309</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2006</year><volume>54</volume><fpage>2951</fpage><lpage>2962</lpage><pub-id pub-id-type="doi">10.1002/art.22044</pub-id><?supplied-pmid 16947629?><pub-id pub-id-type="pmid">16947629</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landolt-Marticorena</surname><given-names>C</given-names></name><etal/></person-group><article-title>Lack of association between the interferon-alpha signature and longitudinal changes in disease activity in systemic lupus erythematosus</article-title><source>Ann Rheum Dis</source><year>2009</year><volume>68</volume><fpage>1440</fpage><lpage>1446</lpage><pub-id pub-id-type="doi">10.1136/ard.2008.093146</pub-id><?supplied-pmid 18772188?><pub-id pub-id-type="pmid">18772188</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiche</surname><given-names>L</given-names></name><etal/></person-group><article-title>Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures</article-title><source>Arthritis &#x00026;amp; Rheumatology</source><year>2014</year><volume>66</volume><fpage>1583</fpage><lpage>1595</lpage><pub-id pub-id-type="doi">10.1002/art.38628</pub-id><pub-id pub-id-type="pmid">24644022</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>AM</given-names></name><etal/></person-group><article-title>SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature</article-title><source>PloS one</source><year>2013</year><volume>8</volume><fpage>e67003</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0067003</pub-id><?supplied-pmid 23826184?><pub-id pub-id-type="pmid">23826184</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Individuality and variation in gene expression patterns in human blood</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>1896</fpage><lpage>1901</lpage><pub-id pub-id-type="doi">10.1073/pnas.252784499</pub-id><?supplied-pmid 12578971?><pub-id pub-id-type="pmid">12578971</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>BW</given-names></name><etal/></person-group><article-title>Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients</article-title><source>Int J Rheum Dis</source><year>2012</year><volume>15</volume><fpage>25</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1111/j.1756-185X.2011.01654.x</pub-id><?supplied-pmid 22324944?><pub-id pub-id-type="pmid">22324944</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><?supplied-pmid 20725040?><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2009</year><volume>60</volume><fpage>1785</fpage><lpage>1796</lpage><pub-id pub-id-type="doi">10.1002/art.24557</pub-id><?supplied-pmid 19479852?><pub-id pub-id-type="pmid">19479852</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>Yihong</given-names></name><name><surname>Higgs</surname><given-names>Brandon W</given-names></name><name><surname>Richman</surname><given-names>Laura</given-names></name><name><surname>White</surname><given-names>Barbara</given-names></name><name><surname>Jallal</surname><given-names>Bahija</given-names></name></person-group><article-title>Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFN&#x003b1; antibody, in systemic lupus erythematosus</article-title><source>Arthritis Research &#x00026; Therapy</source><year>2010</year><volume>12</volume><issue>Suppl 1</issue><fpage>S6</fpage><pub-id pub-id-type="doi">10.1186/ar2887</pub-id><pub-id pub-id-type="pmid">20392292</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identification of interferon-inducible genes as diagnostic biomarker for systemic lupus erythematosus</article-title><source>Clin Rheumatol</source><year>2015</year><volume>34</volume><fpage>71</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1007/s10067-014-2799-4</pub-id><?supplied-pmid 25344775?><pub-id pub-id-type="pmid">25344775</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>L</given-names></name><etal/></person-group><article-title>Interferon and granulopoiesis signatures in systemic lupus erythematosus blood</article-title><source>The Journal of experimental medicine</source><year>2003</year><volume>197</volume><fpage>711</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1084/jem.20021553</pub-id><?supplied-pmid 12642603?><pub-id pub-id-type="pmid">12642603</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><etal/></person-group><article-title>Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus</article-title><source>Proc Natl Acad Sci USA</source><year>2003</year><volume>100</volume><fpage>2610</fpage><lpage>2615</lpage><pub-id pub-id-type="doi">10.1073/pnas.0337679100</pub-id><?supplied-pmid 12604793?><pub-id pub-id-type="pmid">12604793</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>M</given-names></name><etal/></person-group><article-title>Fluctuations in the gene expression of peripheral blood mononuclear cells between the active and inactive phases of systemic lupus erythematosus</article-title><source>Clin Exp Rheumatol</source><year>2010</year><volume>28</volume><fpage>311</fpage><lpage>317</lpage><?supplied-pmid 20460036?><pub-id pub-id-type="pmid">20460036</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus</article-title><source>Arthritis Rheum</source><year>2004</year><volume>50</volume><fpage>3958</fpage><lpage>3967</lpage><pub-id pub-id-type="doi">10.1002/art.20798</pub-id><?supplied-pmid 15593221?><pub-id pub-id-type="pmid">15593221</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fayyaz</surname><given-names>A</given-names></name><etal/></person-group><article-title>Haematological manifestations of lupus</article-title><source>Lupus Sci Med</source><year>2015</year><volume>2</volume><fpage>e000078</fpage><pub-id pub-id-type="doi">10.1136/lupus-2014-000078</pub-id><?supplied-pmid 25861458?><pub-id pub-id-type="pmid">25861458</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>FH</given-names></name></person-group><article-title>An index of factorial simplicity</article-title><source>Psychometrika</source><year>1974</year><volume>39</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/BF02291575</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Care</surname><given-names>Matthew A.</given-names></name><name><surname>Stephenson</surname><given-names>Sophie J.</given-names></name><name><surname>Barnes</surname><given-names>Nicholas A.</given-names></name><name><surname>Fan</surname><given-names>Im</given-names></name><name><surname>Zougman</surname><given-names>Alexandre</given-names></name><name><surname>El-Sherbiny</surname><given-names>Yasser M.</given-names></name><name><surname>Vital</surname><given-names>Edward M.</given-names></name><name><surname>Westhead</surname><given-names>David R.</given-names></name><name><surname>Tooze</surname><given-names>Reuben M.</given-names></name><name><surname>Doody</surname><given-names>Gina M.</given-names></name></person-group><article-title>Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity</article-title><source>The Journal of Immunology</source><year>2016</year><volume>197</volume><issue>4</issue><fpage>1447</fpage><lpage>1459</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1600624</pub-id><pub-id pub-id-type="pmid">27357150</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crow</surname><given-names>MK</given-names></name><name><surname>Kirou</surname><given-names>KA</given-names></name><name><surname>Wohlgemuth</surname><given-names>J</given-names></name></person-group><article-title>Microarray analysis of interferon-regulated genes in SLE</article-title><source>Autoimmunity</source><year>2003</year><volume>36</volume><fpage>481</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.1080/08916930310001625952</pub-id><pub-id pub-id-type="pmid">14984025</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aletaha</surname><given-names>D</given-names></name><etal/></person-group><article-title>2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative</article-title><source>Ann Rheum Dis</source><year>2010</year><volume>69</volume><fpage>1580</fpage><lpage>1588</lpage><pub-id pub-id-type="doi">10.1136/ard.2010.138461</pub-id><?supplied-pmid 20699241?><pub-id pub-id-type="pmid">20699241</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isenberg</surname><given-names>DA</given-names></name><etal/></person-group><article-title>BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group&#x02019;s disease activity index for patients with systemic lupus erythematosus</article-title><source>Rheumatology (Oxford)</source><year>2005</year><volume>44</volume><fpage>902</fpage><lpage>906</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/keh624</pub-id><pub-id pub-id-type="pmid">15814577</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higgs</surname><given-names>BW</given-names></name><etal/></person-group><article-title>Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway</article-title><source>Ann Rheum Dis</source><year>2011</year><volume>70</volume><fpage>2029</fpage><lpage>2036</lpage><pub-id pub-id-type="doi">10.1136/ard.2011.150326</pub-id><?supplied-pmid 21803750?><pub-id pub-id-type="pmid">21803750</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petri</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials</article-title><source>Arthritis Rheum</source><year>2013</year><volume>65</volume><fpage>2143</fpage><lpage>2153</lpage><pub-id pub-id-type="doi">10.1002/art.37995</pub-id><?supplied-pmid 23754628?><pub-id pub-id-type="pmid">23754628</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>T</given-names></name><etal/></person-group><article-title>NCBI GEO: archive for functional genomics data sets&#x02013;update</article-title><source>Nucleic Acids Res</source><year>2013</year><volume>41</volume><fpage>D991</fpage><lpage>995</lpage><pub-id pub-id-type="doi">10.1093/nar/gks1193</pub-id><?supplied-pmid 23193258?><pub-id pub-id-type="pmid">23193258</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kupershmidt</surname><given-names>Ilya</given-names></name><name><surname>Su</surname><given-names>Qiaojuan Jane</given-names></name><name><surname>Grewal</surname><given-names>Anoop</given-names></name><name><surname>Sundaresh</surname><given-names>Suman</given-names></name><name><surname>Halperin</surname><given-names>Inbal</given-names></name><name><surname>Flynn</surname><given-names>James</given-names></name><name><surname>Shekar</surname><given-names>Mamatha</given-names></name><name><surname>Wang</surname><given-names>Helen</given-names></name><name><surname>Park</surname><given-names>Jenny</given-names></name><name><surname>Cui</surname><given-names>Wenwu</given-names></name><name><surname>Wall</surname><given-names>Gregory D.</given-names></name><name><surname>Wisotzkey</surname><given-names>Robert</given-names></name><name><surname>Alag</surname><given-names>Satnam</given-names></name><name><surname>Akhtari</surname><given-names>Saeid</given-names></name><name><surname>Ronaghi</surname><given-names>Mostafa</given-names></name></person-group><article-title>Ontology-Based Meta-Analysis of Global Collections of High-Throughput Public Data</article-title><source>PLoS ONE</source><year>2010</year><volume>5</volume><issue>9</issue><fpage>e13066</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0013066</pub-id><pub-id pub-id-type="pmid">20927376</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemer</surname><given-names>AB</given-names></name><name><surname>Keskin</surname><given-names>DB</given-names></name><name><surname>Reinherz</surname><given-names>EL</given-names></name></person-group><article-title>Identification and validation of reference genes for expression studies in human keratinocyte cell lines treated with and without interferon-gamma - a method for qRT-PCR reference gene determination</article-title><source>Experimental dermatology</source><year>2012</year><volume>21</volume><fpage>625</fpage><lpage>629</lpage><pub-id pub-id-type="doi">10.1111/j.1600-0625.2012.01537.x</pub-id><?supplied-pmid 22775998?><pub-id pub-id-type="pmid">22775998</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCall</surname><given-names>MN</given-names></name><name><surname>McMurray</surname><given-names>HR</given-names></name><name><surname>Land</surname><given-names>H</given-names></name><name><surname>Almudevar</surname><given-names>A</given-names></name></person-group><article-title>On non-detects in qPCR data</article-title><source>Bioinformatics</source><year>2014</year><volume>30</volume><fpage>2310</fpage><lpage>2316</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu239</pub-id><?supplied-pmid 24764462?><pub-id pub-id-type="pmid">24764462</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>HF</given-names></name></person-group><article-title>An Index of Factorial Simplicity</article-title><source>Psychometrika</source><year>1974</year><volume>39</volume><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1007/BF02291575</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">Cohen, J. <italic>Statistical power analysis for the behavioral sciences</italic>. 2nd edn, (L. Erlbaum Associates, 1988).</mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flint</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases</article-title><source>RMD Open</source><year>2016</year><volume>2</volume><fpage>e000183</fpage><pub-id pub-id-type="doi">10.1136/rmdopen-2015-000183</pub-id><?supplied-pmid 27252891?><pub-id pub-id-type="pmid">27252891</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyogoku</surname><given-names>C</given-names></name><etal/></person-group><article-title>Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?</article-title><source>PloS one</source><year>2013</year><volume>8</volume><fpage>e83776</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0083776</pub-id><?supplied-pmid 24391825?><pub-id pub-id-type="pmid">24391825</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikpour</surname><given-names>M</given-names></name><name><surname>Dempsey</surname><given-names>AA</given-names></name><name><surname>Urowitz</surname><given-names>MB</given-names></name><name><surname>Gladman</surname><given-names>DD</given-names></name><name><surname>Barnes</surname><given-names>DA</given-names></name></person-group><article-title>Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus</article-title><source>Ann Rheum Dis</source><year>2008</year><volume>67</volume><fpage>1069</fpage><lpage>1075</lpage><pub-id pub-id-type="doi">10.1136/ard.2007.074765</pub-id><?supplied-pmid 18063674?><pub-id pub-id-type="pmid">18063674</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>PA</given-names></name><etal/></person-group><article-title>Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis</article-title><source>Ann Rheum Dis</source><year>2010</year><volume>69</volume><fpage>1208</fpage><lpage>1213</lpage><pub-id pub-id-type="doi">10.1136/ard.2009.108043</pub-id><?supplied-pmid 19815495?><pub-id pub-id-type="pmid">19815495</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease</article-title><source>Arthritis Rheum</source><year>2005</year><volume>52</volume><fpage>1491</fpage><lpage>1503</lpage><pub-id pub-id-type="doi">10.1002/art.21031</pub-id><?supplied-pmid 15880830?><pub-id pub-id-type="pmid">15880830</pub-id></element-citation></ref></